Dyson, Kyle A.
Stover, Brian D.
Grippin, Adam
Mendez-Gomez, Hector R.
Lagmay, Joanne
Mitchell, Duane A.
Sayour, Elias J.
Article History
Received: 23 January 2019
Accepted: 14 June 2019
First Online: 16 July 2019
Ethics approval and consent to participate
: N/A
: N/A
: Duane A. Mitchell holds ownership interest (including patents) in iOncologi, Inc. Duane A. Mitchell has patented immunotherapy-related technology that has been licensed by Annias Immunotherapeutics, Inc., Celldex Therapeutics, Inc., and Immunomic Therapeutics, Inc. The other authors declare no conflicts of interest.